Dimitri–Sturge–Weber syndrome

From WikiMD's WELLNESSPEDIA

Dimitri–Sturge–Weber syndrome (DSWS), also known as Sturge-Weber syndrome or encephalotrigeminal angiomatosis, is a rare congenital neurological disorder and skin disorder. It is characterized by a port-wine stain birthmark on the face, neurological abnormalities, and vascular eye abnormalities. DSWS is associated with a somatic mutation in the GNAQ gene, which occurs sporadically and is not inherited. The syndrome affects the development of certain blood vessels, causing abnormalities in the brain, skin, and eyes.

Symptoms and Signs[edit]

The most visible sign of Dimitri–Sturge–Weber syndrome is a facial port-wine stain, typically affecting one side of the face. The extent and location of the stain can vary. Additional symptoms include:

Causes[edit]

DSWS is caused by a somatic mutation in the GNAQ gene, which is not inherited but occurs randomly in a cell during early development. The GNAQ gene regulates blood vessel formation, and its mutation leads to the abnormal development of blood vessels in the brain, skin, and eyes associated with the syndrome.

Diagnosis[edit]

Diagnosis is based on clinical presentation, including:

Treatment[edit]

There is no cure for Dimitri–Sturge–Weber syndrome. Treatment focuses on managing symptoms and preventing complications, including:

  • Anticonvulsant medications: To control seizures.
  • Laser therapy: To reduce the appearance of the port-wine stain.
  • Regular eye examinations: To detect and treat glaucoma early.
  • Supportive therapies:
  • Physical therapy and occupational therapy to address developmental delays.
  • Educational support for intellectual disabilities.

Prognosis[edit]

The prognosis for individuals with DSWS varies widely depending on the severity of symptoms. Early and proactive management of seizures and glaucoma can significantly improve quality of life and outcomes.

See Also[edit]








NIH genetic and rare disease info[edit]

Dimitri–Sturge–Weber syndrome is a rare disease.